Preferred Name

ANTAZOLINE

ID

http://purl.bioontology.org/ontology/NDFRT/N0000147709

contraindicated_with_disease

http://purl.bioontology.org/ontology/NDFRT/N0000000999

http://purl.bioontology.org/ontology/NDFRT/N0000003321

cui

C0003143

FDA_UNII_CODE

DHA8014SS1

has_ingredient

http://purl.bioontology.org/ontology/NDFRT/N0000006006

has_mechanism_of_action

http://purl.bioontology.org/ontology/NDFRT/N0000000190

has_physiologic_effect

http://purl.bioontology.org/ontology/NDFRT/N0000008657

hasSTY

http://purl.bioontology.org/ontology/STY/T109

http://purl.bioontology.org/ontology/STY/T121

LEVEL

Ingredient

may_treat

http://purl.bioontology.org/ontology/NDFRT/N0000002595

http://purl.bioontology.org/ontology/NDFRT/N0000000835

http://purl.bioontology.org/ontology/NDFRT/N0000002512

NDFRT_KIND

DRUG_KIND

notation

N0000147709

NUI

N0000147709

prefLabel

ANTAZOLINE

tui

T109

T121

VANDF_RECORD

50.6^1545^Active/Master

50.416^2234^Active/Master

VUID

4019615

subClassOf

http://purl.bioontology.org/ontology/NDFRT/N0000010583

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
There are currently no mappings for this class.